Antitubercular agents. Part 2: New thiolactomycin analogues active against Mycobacterium tuberculosis
- 1 April 2005
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 15 (7), 1927-1929
- https://doi.org/10.1016/j.bmcl.2005.01.084
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Analogues of thiolactomycin: potential drugs with enhanced anti-mycobacterial activity a aDetails for the preparation of the thiolactomycin analogues shown in Table 1 are available as supplementary data in Microbiology Online (http://mic.sgmjournals.org).Microbiology, 2002
- Current status and future development of antitubercular chemotherapyExpert Opinion on Investigational Drugs, 2002
- Bacterial Fatty Acid Biosynthesis: Targets for Antibacterial Drug DiscoveryAnnual Review of Microbiology, 2001
- Inhibition of β-Ketoacyl-Acyl Carrier Protein Synthases by Thiolactomycin and CeruleninJournal of Biological Chemistry, 2001
- Thiolactomycin and Related Analogues as Novel Anti-mycobacterial Agents Targeting KasA and KasB Condensing Enzymes inMycobacterium tuberculosisPublished by Elsevier BV ,2000
- Global Burden of TuberculosisJAMA, 1999
- Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequenceNature, 1998
- SHORT-COURSE CHEMOPROPHYLAXIS FOR TUBERCULOSISClinics in Chest Medicine, 1997
- Total ssynthesis of (±) thiolactomycinTetrahedron Letters, 1984
- Thiolactomycin, a new antibiotic. I. Taxonomy of the producing organism, fermentation and biological properties.The Journal of Antibiotics, 1982